Ketamine/xylazine anesthesia is safe in hemorheological point of view: a preliminary report Ketamin/ksilazin anestezi hemoreolojik bakış açısından güvenlidir: bir ilk rapor


Akbudak İ. H., Erkek O. K., Tuzcu E. B., Pakyurek H., Kucukatay M. B.

Pamukkale Medical Journal, cilt.14, sa.2, ss.444-450, 2021 (Scopus, TRDizin) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.31362/patd.839939
  • Dergi Adı: Pamukkale Medical Journal
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.444-450
  • Anahtar Kelimeler: anesthesia, erythocyte deformability, Ketamin/xylazine, rat, viscosity
  • Uşak Üniversitesi Adresli: Hayır

Özet

Purpose: Some anesthetic drugs are known to have influence on circulation due to hemorheological effects. We aimed to investigate the possible effects of ketamin-xylazine anesthesia, which is extensively used in experimental animal laboratories on hemorheological parameters. Materials and methods: Adult, male Wistar-Albino rats were divided into two as control (pre-anesthesia) and post-anesthesia (n=17). Ketamin-HCl/Xylazine-HCl (90 mg/kg-10 mg/kg) were injected intraperitoneally. Intracardiac heparinized blood was collected either without anesthesia (control group) or after anesthesia (post-anesthesia group) following the loss of reflexes such as righting, cornea and withdrawal. Erythrocyte deformability was determined by an ektacytometer, while WBV (at shear rates of 38, 76 and 190 s-1) and PV (at 190 s-1 shear rate) at standard (40%) and otolog hematocrit (Hct) were measured via a cone-plate rotational viscometer. Results: Mean time taken for the disappearance of righting reflex was 4±3.6, corneal reflex 8±6.8 and for withdrawal reflex 10±6.7 min. 90 mg/kg Ketamin-10 mg/kg Xylazine administration did not affect RBC deformability, WBV and PV of the rats. Conclusion: These results demonstrate that, use of Ketamin/Xylazine anesthesia may be recommended especially when dealing with hemorheological, cardiovascular and hematological parameters.